The alopecia treatment market includes products used in the treatment of hair loss conditions such as androgenic alopecia, alopecia areata, and telogen effluvium. Some common treatment products are topical drugs, oral drugs, and other treatment types. Topical drugs include minoxidil solutions and topical corticosteroids that aid hair growth when applied to the scalp. Oral drugs comprise 5-alpha reductase inhibitors and other medications taken orally to treat androgenic alopecia. Other treatment types involve low-level laser therapies, platelet-rich plasma therapies, and hair transplant surgeries.
The global alopecia treatment market is estimated to be valued at US$ 10.2 Bn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the alopecia treatment market include Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
The alopecia treatment market provides various opportunities such as technological advancements in regenerative medicine approaches for permanent hair loss treatment. Companies are developing hair regenerative therapies using autologous cell therapies and regenerative drugs.
Recent advancements in hair regenerative therapies including autologous cell-based therapies and regenerative drugs are expected to provide permanent treatment for alopecia in the future. Companies are developing therapies involving follicular unit extraction and implantation, and MSC injections to restore lost hair follicles.
Market Drivers
The increasing prevalence of alopecia disorders globally is a key factor driving the alopecia treatment market growth. For instance, alopecia areata impacts nearly 2% of the world population at some point in their life. Additionally, the rising awareness about various alopecia treatment options and technological improvements in hair restoration procedures are further augmenting the market expansion.
Challenges in the Alopecia Treatment Market:
The alopecia treatment market is facing several challenges currently. Some of the key challenges are lack of approved therapies, high treatment costs, limited understanding of disease pathology. Alopecia can have significant psychological impact on patients but there is still limited awareness about different types of hair loss conditions and available treatment options. Early diagnosis of alopecia is also a challenge due to nonspecific symptoms in initial stages. Developing effective and safe therapies that can target root cause of different alopecia conditions is one of the major focus areas for players in this market.
SWOT Analysis
Strength: Growing prevalence of alopecia disorders worldwide is driving the market. Advancements in treatment technologies and development of novel therapies offer better treatment outcomes.
Weakness: High treatment costs and lack of insurance coverage or reimbursement in many countries. Limited knowledge about alopecia pathogenesis pose challenges in developing curative therapies.
Opportunity: Untapped markets in developing regions present lucrative opportunities. Increasing focus on R&D of therapies targeting disease mechanisms will expand treatment options.
Threats: Stringent regulatory approval process increases complexity and costs. Patent expiries of blockbuster drugs open up space for generic competition.
Geographical Regions
North America holds the major share of alopecia treatment market currently due to increasing baldness prevalence, high healthcare spending and presence of key market players. The US dominates the North America market.
Asia Pacific region is expected to witness the fastest growth during forecast period owing to rising disposable income, growing awareness and expansion of healthcare infrastructure in emerging countries. Rapidly aging population in countries like China and India will further drive the alopecia treatment demand in Asia Pacific.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it